BACKGROUND: The first carpometacarpal (CMC) joint is a common site of osteoarthritis, with arthroplasty being a common procedure to provide pain relief and improve function with low complications. However, little is known about risk factors that may predispose a patient for postoperative complications. METHODS: All CMC joint arthroplasty from 2005 to 2015 in the prospectively collected American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database were identified. Bivariate testing and multiple logistic regressions were performed to determine which patient demographics, surgical variables and medical comorbidities were significant predictors for complications. These included wound related, cardiopulmonary, neurological and renal complications, return to the operating room (OR) and readmission. RESULTS: A total of 3344 patients were identified from the database. Of those, 45 patients (1.3%) experienced a complication including wound issues (0.66%), return to the OR (0.15%) and readmission (0.27%) amongst others. When performing bivariate analysis, age over 65, American Society of Anesthesiologists (ASA) Class, diabetes and renal dialysis were significant risk factors. Multiple logistic regression after adjusting for confounding factors demonstrated that insulin-dependent diabetes and ASA Class 4 had a strong trend while renal dialysis was a significant risk factor. CONCLUSIONS: CMC arthroplasty has a very low overall complication rate of 1.3% and wound complication rate of 0.66%. Diabetes requiring insulin and ASA Class 4 trended towards significance while renal dialysis was found to be a significant risk factors in logistic regression. This information may be useful for preoperative counseling and discussion with patients who have these risk factors.
BACKGROUND: The first carpometacarpal (CMC) joint is a common site of osteoarthritis, with arthroplasty being a common procedure to provide pain relief and improve function with low complications. However, little is known about risk factors that may predispose a patient for postoperative complications. METHODS: All CMC joint arthroplasty from 2005 to 2015 in the prospectively collected American College of Surgeons National Surgical Quality Improvement Program (ACS-NSQIP) database were identified. Bivariate testing and multiple logistic regressions were performed to determine which patient demographics, surgical variables and medical comorbidities were significant predictors for complications. These included wound related, cardiopulmonary, neurological and renal complications, return to the operating room (OR) and readmission. RESULTS: A total of 3344 patients were identified from the database. Of those, 45 patients (1.3%) experienced a complication including wound issues (0.66%), return to the OR (0.15%) and readmission (0.27%) amongst others. When performing bivariate analysis, age over 65, American Society of Anesthesiologists (ASA) Class, diabetes and renal dialysis were significant risk factors. Multiple logistic regression after adjusting for confounding factors demonstrated that insulin-dependent diabetes and ASA Class 4 had a strong trend while renal dialysis was a significant risk factor. CONCLUSIONS:CMC arthroplasty has a very low overall complication rate of 1.3% and wound complication rate of 0.66%. Diabetes requiring insulin and ASA Class 4 trended towards significance while renal dialysis was found to be a significant risk factors in logistic regression. This information may be useful for preoperative counseling and discussion with patients who have these risk factors.
Entities:
Keywords:
NSQIP; readmission; reoperation; surgical complications; thumb CMC arthroplasty
Authors: Bryan D Haughom; William W Schairer; Michael D Hellman; Paul H Yi; Brett R Levine Journal: J Arthroplasty Date: 2014-03-06 Impact factor: 4.757
Authors: Aparajit Naram; Keith Lyons; Douglas M Rothkopf; Edward R Calkins; Thomas Breen; Marci Jones; John V Shufflebarger Journal: Hand (N Y) Date: 2016-01-14
Authors: Philip J Belmont; Gens P Goodman; Brian R Waterman; Julia O Bader; Andrew J Schoenfeld Journal: J Bone Joint Surg Am Date: 2014-01-01 Impact factor: 5.284
Authors: Nelson F Soohoo; Eugene Farng; Jay R Lieberman; Lauchlan Chambers; David S Zingmond Journal: Clin Orthop Relat Res Date: 2010-09 Impact factor: 4.176
Authors: Brian R Waterman; John C Dunn; Julia Bader; Luis Urrea; Andrew J Schoenfeld; Philip J Belmont Journal: J Shoulder Elbow Surg Date: 2014-08-29 Impact factor: 3.019
Authors: Christopher J Goodenough; Cassie A Hartline; Shuyan Wei; Joseph K Moffitt; Alfredo Cepeda; Phuong D Nguyen; Matthew R Greives Journal: Eplasty Date: 2022-09-07